Delix Therapeutics — Non-hallucinogenic psychedelic drugs for mental health
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
Get it by email
Companies like Delix Therapeutics go out every weekday morning. One-click unsubscribe.
- Round
- $100M Series C
- Investors
- SV Health neurodegen fund, Strategic Pharma
- Sectors
- Biotechnology, Data and analytics, Healthcare, Science and engineering
- Logged
- November 9, 2026, in issue #70
- Website
- www.delixtherapeutics.com
More in biotechnology and data and analytics
$1M · galy.co
GALY Co. — Cocoa and cotton grown from cells for brands
GALY grows cocoa and cotton from cells using biological processes, supplying brands with traceable, scalable ingredients without traditional farming.
Information technologyBiotechnology$1M+
$4.7M Seed · getpeppermint.ai
Peppermint — Billing and collections for clinical trial sites
Peppermint is a software company based in San Francisco that focuses on AI-powered financial operations for clinical research teams. It aims to modernize the financial infrastructure used by hospital systems and research sites to manage clinical trials. Founded in 2026, the company provides a platform that automates billing, invoicing, and collections. This platform integrates with existing clinical trial management systems to streamline revenue cycle management.
BiotechnologySoftwareHealthcareEvan MooreBenjamin MannNight Capital · +8 · +11
$16.4M · vescent.com
Vescent Technologies — Frequency combs, lasers and controls for quantum tech
Vescent is leading and enabling the commercialization of Quantum Technologies in the lab and in the field. It has been providing frequency Combs, Lasers, and Controls to 100s of customers on the front lines of scaling the commercial quantum ecosystem throughout the world with low-SWaP, ruggedness, and IP.
ManufacturingBiotechnology$10M+